Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Sep 15;318(Pt 3):1041–1049. doi: 10.1042/bj3181041

Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis.

H Patel 1, J Bramall 1, H Waters 1, M C De Beer 1, P Woo 1
PMCID: PMC1217721  PMID: 8836154

Abstract

Site-directed mutagenesis of the acute-phase human serum amyloid A (SAA1 alpha) protein was used to evaluate the importance of the N-terminal amino acid residues, namely RSFFSFLGEAF The full-length cDNA clone of SAA1 alpha (pA1.mod.) was used to create two mutations, namely Gly-8 to Asp-8 and an 11 amino acid truncation between Arg-1 and Phe-11 respectively. Wild-type and mutant cDNAs were expressed in Chinese hamster ovary (CHO) cells under the control of the human cytomegalovirus promoter, which resulted in the secretion of the processed proteins into the culture media. Wild-type recombinant human SAA (rSAA) protein was shown to have pI values of 6.0 and 6.4, similar to the human SAA isoform SAA1 alpha and SAA1 alpha desArg found in acute-phase plasma. N-terminal sequencing of 56 residues confirmed its identity with human SAA1 alpha. The total yield of wild-type rSAA measured by ELISA was between 3.5 and 30 mg/l. The two mutations resulted in reduced expression levels of the mutant SAA proteins (3-10 mg/l). Further measurements of rSAA concentration in lipid fractions of culture medium collected at a density of 1.21 g/ml (high-density liporotein; HDL) and 1.063-1.18 g/ml (very-low-density lipoprotein/low-density lipoprotein; VLDL/LDL) showed that 76% of the wild-type protein was found in the HDL fraction and the remaining 24% in the infranatant non-lipid fraction. In contrast the relative concentration of mutant rSAA in HDL and infranatant fractions was reversed. This is consistent with the previously proposed involvement of the 11 amino acid peptide in anchoring. SAA protein on to HDL3 [Turnell, Sarra, Glover, Baum, Caspi, Baltz and Pepys (1986) Mol. Biol. Med. 3, 387-407]. Wild-type rSAA protein was shown to from amyloid fibrils in vitro under acidic conditions as shown by electron microscopy, and stained positive with Congo Red and exhibited apple-green birefringence when viewed under polarized light. Under the same conditions mutSAA(G8D) and mutSAA delta 1-11 did not form amyloid fibrils. In conclusion, replacement of Gly-8 by Asp-8 or deletion of the first 11 amino acid residues at the N-terminus of rSAA diminishes its capacity to bind to HDL and decreases amyloid fibril formation.

Full Text

The Full Text of this article is available as a PDF (659.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baba S., Masago S. A., Takahashi T., Kasama T., Sugimura H., Tsugane S., Tsutsui Y., Shirasawa H. A novel allelic variant of serum amyloid A, SAA1 gamma: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis. Hum Mol Genet. 1995 Jun;4(6):1083–1087. doi: 10.1093/hmg/4.6.1083. [DOI] [PubMed] [Google Scholar]
  2. Badolato R., Johnston J. A., Wang J. M., McVicar D., Xu L. L., Oppenheim J. J., Kelvin D. J. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol. 1995 Oct 15;155(8):4004–4010. [PubMed] [Google Scholar]
  3. Beach C. M., De Beer M. C., Sipe J. D., Loose L. D., De Beer F. C. Human serum amyloid A protein. Complete amino acid sequence of a new variant. Biochem J. 1992 Mar 1;282(Pt 2):615–620. doi: 10.1042/bj2820615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Benditt E. P., Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci U S A. 1977 Sep;74(9):4025–4028. doi: 10.1073/pnas.74.9.4025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Betts J. C., Edbrooke M. R., Thakker R. V., Woo P. The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells. Scand J Immunol. 1991 Oct;34(4):471–482. doi: 10.1111/j.1365-3083.1991.tb01570.x. [DOI] [PubMed] [Google Scholar]
  6. Boshart M., Weber F., Jahn G., Dorsch-Häsler K., Fleckenstein B., Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell. 1985 Jun;41(2):521–530. doi: 10.1016/s0092-8674(85)80025-8. [DOI] [PubMed] [Google Scholar]
  7. Bunch D. S., Rocke D. M., Harrison R. O. Statistical design of ELISA protocols. J Immunol Methods. 1990 Sep 14;132(2):247–254. doi: 10.1016/0022-1759(90)90036-u. [DOI] [PubMed] [Google Scholar]
  8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  9. Clifton P. M., Mackinnon A. M., Barter P. J. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. J Lipid Res. 1985 Dec;26(12):1389–1398. [PubMed] [Google Scholar]
  10. Coetzee G. A., Strachan A. F., van der Westhuyzen D. R., Hoppe H. C., Jeenah M. S., de Beer F. C. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem. 1986 Jul 25;261(21):9644–9651. [PubMed] [Google Scholar]
  11. Eisenberg D., Schwarz E., Komaromy M., Wall R. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J Mol Biol. 1984 Oct 15;179(1):125–142. doi: 10.1016/0022-2836(84)90309-7. [DOI] [PubMed] [Google Scholar]
  12. Eisenberg D., Weiss R. M., Terwilliger T. C. The hydrophobic moment detects periodicity in protein hydrophobicity. Proc Natl Acad Sci U S A. 1984 Jan;81(1):140–144. doi: 10.1073/pnas.81.1.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  14. Forte T. M., McCall M. R., Amacher S., Nordhausen R. W., Vigne J. L., Mallory J. B. Physical and chemical characteristics of apolipoprotein A-I-lipid complexes produced by Chinese hamster ovary cells transfected with the human apolipoprotein A-I gene. Biochim Biophys Acta. 1990 Oct 22;1047(1):11–18. doi: 10.1016/0005-2760(90)90254-u. [DOI] [PubMed] [Google Scholar]
  15. Hoffman J. S., Ericsson L. H., Eriksen N., Walsh K. A., Benditt E. P. Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products. J Exp Med. 1984 Feb 1;159(2):641–646. doi: 10.1084/jem.159.2.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Husebekk A., Skogen B., Husby G., Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol. 1985 Mar;21(3):283–287. doi: 10.1111/j.1365-3083.1985.tb01431.x. [DOI] [PubMed] [Google Scholar]
  17. Kisilevsky R., Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest. 1992 Jun;66(6):778–785. [PubMed] [Google Scholar]
  18. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  19. Liang J. S., Sipe J. D. Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux. J Lipid Res. 1995 Jan;36(1):37–46. [PubMed] [Google Scholar]
  20. Liepnieks J. J., Kluve-Beckerman B., Benson M. D. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1. Biochim Biophys Acta. 1995 Jan 25;1270(1):81–86. doi: 10.1016/0925-4439(94)00076-3. [DOI] [PubMed] [Google Scholar]
  21. Linke R. P., Bock V., Valet G., Rothe G. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem Biophys Res Commun. 1991 May 15;176(3):1100–1105. doi: 10.1016/0006-291x(91)90397-p. [DOI] [PubMed] [Google Scholar]
  22. Lowell C. A., Potter D. A., Stearman R. S., Morrow J. F. Structure of the murine serum amyloid A gene family. Gene conversion. J Biol Chem. 1986 Jun 25;261(18):8442–8452. [PubMed] [Google Scholar]
  23. Meek R. L., Hoffman J. S., Benditt E. P. Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation. J Exp Med. 1986 Mar 1;163(3):499–510. doi: 10.1084/jem.163.3.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Meek R. L., Urieli-Shoval S., Benditt E. P. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3186–3190. doi: 10.1073/pnas.91.8.3186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pruzanski W., de Beer F. C., de Beer M. C., Stefanski E., Vadas P. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. Biochem J. 1995 Jul 15;309(Pt 2):461–464. doi: 10.1042/bj3090461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Raynes J. G., McAdam K. P. Serum amyloid A isoforms in inflammation. Scand J Immunol. 1991 Jun;33(6):657–666. doi: 10.1111/j.1365-3083.1991.tb02538.x. [DOI] [PubMed] [Google Scholar]
  27. Schmidt E. V., Christoph G., Zeller R., Leder P. The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol Cell Biol. 1990 Aug;10(8):4406–4411. doi: 10.1128/mcb.10.8.4406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sipe J. D., Colten H. R., Goldberger G., Edge M. D., Tack B. F., Cohen A. S., Whitehead A. S. Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry. 1985 Jun 4;24(12):2931–2936. doi: 10.1021/bi00333a018. [DOI] [PubMed] [Google Scholar]
  29. Skogen B., Natvig J. B., Bøorresen A. L., Berg K. Degradation of amyloid-related serum protein SAA by a component present in rabbit and human serum. Scand J Immunol. 1980;11(6):643–648. doi: 10.1111/j.1365-3083.1980.tb00033.x. [DOI] [PubMed] [Google Scholar]
  30. Steinmetz A., Hocke G., Saïle R., Puchois P., Fruchart J. C. Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim Biophys Acta. 1989 Nov 28;1006(2):173–178. doi: 10.1016/0005-2760(89)90192-6. [DOI] [PubMed] [Google Scholar]
  31. Strachan A. F., Brandt W. F., Woo P., van der Westhuyzen D. R., Coetzee G. A., de Beer M. C., Shephard E. G., de Beer F. C. Human serum amyloid A protein. The assignment of the six major isoforms to three published gene sequences and evidence for two genetic loci. J Biol Chem. 1989 Nov 5;264(31):18368–18373. [PubMed] [Google Scholar]
  32. Strachan A. F., Shephard E. G., Bellstedt D. U., Coetzee G. A., van der Westhuyzen D. R., de Beer F. C. Human serum amyloid A protein. Behaviour in aqueous and urea-containing solutions and antibody production. Biochem J. 1989 Oct 15;263(2):365–370. doi: 10.1042/bj2630365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Strachan A. F., de Beer F. C., van der Westhuyzen D. R., Coetzee G. A. Identification of three isoform patterns of human serum amyloid A protein. Biochem J. 1988 Feb 15;250(1):203–207. doi: 10.1042/bj2500203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Turnell W. G., Finch J. T. Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequences. J Mol Biol. 1992 Oct 20;227(4):1205–1223. doi: 10.1016/0022-2836(92)90532-o. [DOI] [PubMed] [Google Scholar]
  36. Turnell W., Sarra R., Baum J. O., Caspi D., Baltz M. L., Pepys M. B. X-ray scattering and diffraction by wet gels of AA amyloid fibrils. Mol Biol Med. 1986 Oct;3(5):409–424. [PubMed] [Google Scholar]
  37. Turnell W., Sarra R., Glover I. D., Baum J. O., Caspi D., Baltz M. L., Pepys M. B. Secondary structure prediction of human SAA1. Presumptive identification of calcium and lipid binding sites. Mol Biol Med. 1986 Oct;3(5):387–407. [PubMed] [Google Scholar]
  38. Watson G., Coade S., Woo P. Analysis of the genomic and derived protein structure of a novel human serum amyloid A gene, SAA4. Scand J Immunol. 1992 Nov;36(5):703–712. doi: 10.1111/j.1365-3083.1992.tb03131.x. [DOI] [PubMed] [Google Scholar]
  39. Westermark G. T., Engström U., Westermark P. The N-terminal segment of protein AA determines its fibrillogenic property. Biochem Biophys Res Commun. 1992 Jan 15;182(1):27–33. doi: 10.1016/s0006-291x(05)80107-x. [DOI] [PubMed] [Google Scholar]
  40. Westermark G. T., Sletten K., Grubb A., Westermark P. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product. Am J Pathol. 1990 Aug;137(2):377–383. [PMC free article] [PubMed] [Google Scholar]
  41. Whitehead A. S., de Beer M. C., Steel D. M., Rits M., Lelias J. M., Lane W. S., de Beer F. C. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem. 1992 Feb 25;267(6):3862–3867. [PubMed] [Google Scholar]
  42. Xu L., Badolato R., Murphy W. J., Longo D. L., Anver M., Hale S., Oppenheim J. J., Wang J. M. A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. J Immunol. 1995 Aug 1;155(3):1184–1190. [PubMed] [Google Scholar]
  43. Yamada T., Kluve-Beckerman B., Liepnieks J. J., Benson M. D. Fibril formation from recombinant human serum amyloid A. Biochim Biophys Acta. 1994 Jul 18;1226(3):323–329. doi: 10.1016/0925-4439(94)90044-2. [DOI] [PubMed] [Google Scholar]
  44. Yamada T., Kluve-Beckerman B., Liepnieks J. J., Benson M. D. In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: possible protection against amyloid fibril formation. Scand J Immunol. 1995 Jun;41(6):570–574. doi: 10.1111/j.1365-3083.1995.tb03609.x. [DOI] [PubMed] [Google Scholar]
  45. de Beer M. C., Beach C. M., Shedlofsky S. I., de Beer F. C. Identification of a novel serum amyloid A protein in BALB/c mice. Biochem J. 1991 Nov 15;280(Pt 1):45–49. doi: 10.1042/bj2800045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. de Beer M. C., de Beer F. C., McCubbin W. D., Kay C. M., Kindy M. S. Structural prerequisites for serum amyloid A fibril formation. J Biol Chem. 1993 Sep 25;268(27):20606–20612. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES